Medexus Pharmaceuticals Inc. (TSX:MDP)

Canada flag Canada · Delayed Price · Currency is CAD
2.850
+0.010 (0.35%)
Feb 9, 2026, 4:00 PM EST
Market Cap92.06M -24.3%
Revenue (ttm)145.00M -0.6%
Net Income530.69K -83.4%
EPS0.02 -85.6%
Shares Out32.30M
PE Ratio159.54
Forward PE11.00
Dividendn/a
Ex-Dividend Daten/a
Volume13,417
Average Volume41,030
Open2.750
Previous Close2.840
Day's Range2.750 - 2.890
52-Week Range1.960 - 3.610
Beta1.97
RSI50.36
Earnings DateFeb 11, 2026

About Medexus Pharmaceuticals

Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; GRAFAPEX, an injection ... [Read more]

Sector Healthcare
Founded 2000
Employees 91
Stock Exchange Toronto Stock Exchange
Ticker Symbol MDP
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements